Nan Bi

Chinese Academy of Medical Sciences & Peking Union Medical College

Papers

Total Citations

244

H-Index

About

Nan Bi is a leading oncologist whose research focuses on the epidemiology and treatment of lung cancer, particularly within the Chinese population. Her landmark 2020 study, "Lung Cancer in People’s Republic of China," with 244 citations, provides a comprehensive analysis of the disease’s unique patterns and risk factors in the region, shaping public health strategies and clinical guidelines. Bi’s work bridges molecular biology and population health, exploring genetic susceptibilities and environmental exposures that drive lung cancer disparities. Her contributions have advanced personalized medicine approaches, improving early detection and therapeutic outcomes for patients. Beyond her highly cited paper, Bi has published extensively on targeted therapies and immunotherapy, earning recognition as a key voice in global oncology. Her research not only illuminates the burden of lung cancer in China but also offers actionable insights for reducing mortality worldwide, making her a pivotal figure in the fight against this devastating disease.